Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023

BUY
$0.29 - $0.57 $4,706 - $9,250
16,229 Added 234.42%
23,152 $9,000
Q3 2022

Oct 07, 2022

BUY
$0.53 - $1.9 $2,268 - $8,132
4,280 Added 161.94%
6,923 $4,000
Q2 2022

Jul 20, 2022

BUY
$1.58 - $7.36 $4,175 - $19,452
2,643 New
2,643 $4,000

About Tonix Pharmaceuticals Holding Corp.


  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.81M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.